Barclays Maintains Underweight on Medpace Hldgs, Lowers Price Target to $500

Medpace +1.81%

Medpace

MEDP

475.23

+1.81%

Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ: MEDP) with a Underweight and lowers the price target from $525 to $500.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via